Matches in Wikidata for { <http://www.wikidata.org/entity/Q64817282> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q64817282 description "clinical trial" @default.
- Q64817282 description "ensayu clínicu" @default.
- Q64817282 description "klinisch onderzoek" @default.
- Q64817282 description "клінічне випробування" @default.
- Q64817282 name "A Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab (AryoGen Pharmed) Compared With Bevacizumab (Avastin®) in Metastatic Colorectal Cancer" @default.
- Q64817282 type Item @default.
- Q64817282 label "A Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab (AryoGen Pharmed) Compared With Bevacizumab (Avastin®) in Metastatic Colorectal Cancer" @default.
- Q64817282 prefLabel "A Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab (AryoGen Pharmed) Compared With Bevacizumab (Avastin®) in Metastatic Colorectal Cancer" @default.
- Q64817282 P1132 Q64817282-CE766689-CC31-42B7-AEC3-34AFEA7BEB65 @default.
- Q64817282 P1476 Q64817282-84FDC627-39D8-4FD9-96B6-D480E6075DB9 @default.
- Q64817282 P2899 Q64817282-839F7BC4-0862-4C41-B24C-5AAA6706E986 @default.
- Q64817282 P3098 Q64817282-57B89108-82FE-4777-AB4C-049A55EA8436 @default.
- Q64817282 P31 Q64817282-1E852BDD-CCBA-408B-B03C-1930EBD94D50 @default.
- Q64817282 P4135 Q64817282-7F863AD9-E0DD-40D0-A4CB-48BFA11F65F4 @default.
- Q64817282 P4844 Q64817282-29F8BCE1-B9CC-4022-8533-BFF2473D333C @default.
- Q64817282 P4844 Q64817282-B92988F3-E1E5-4470-85F6-8C0FA35700B7 @default.
- Q64817282 P580 Q64817282-0BAF6C61-7994-4EE4-9E37-6A999CACDC88 @default.
- Q64817282 P582 Q64817282-8B2D3BA2-6FED-4B66-89CA-5151DF1183E0 @default.
- Q64817282 P6099 Q64817282-255096AF-C849-4AD3-A1D8-1FFE1A95F0E0 @default.
- Q64817282 P8363 Q64817282-7F01CDFD-467B-4F13-9F10-05D9585ABB8D @default.
- Q64817282 P1132 "+126" @default.
- Q64817282 P1476 "A Phase III, Randomized, Two-armed, Double-blind (Patient and Assessors), Parallel Active Controlled Non-Inferiority Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab (Produced by AryoGen Pharmed) Plus FOLFIRI-3 Compared With Bevacizumab (Avastin®) Plus FOLFIRI-3 in Patients With Metastatic Colorectal Cancer (mCRC)" @default.
- Q64817282 P2899 "+18" @default.
- Q64817282 P3098 "NCT03288987" @default.
- Q64817282 P31 Q30612 @default.
- Q64817282 P4135 "+75" @default.
- Q64817282 P4844 Q412197 @default.
- Q64817282 P4844 Q413299 @default.
- Q64817282 P580 "2016-10-05T00:00:00Z" @default.
- Q64817282 P582 "2018-07-30T00:00:00Z" @default.
- Q64817282 P6099 Q42824827 @default.
- Q64817282 P8363 Q78089383 @default.